We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$2.76B
AUM Growth
+$477M
Cap. Flow
+$293M
Cap. Flow %
10.64%
Top 10 Hldgs %
40.13%
Holding
124
New
45
Increased
34
Reduced
15
Closed
23

Top Buys

Rank Stock Value
1
WSM icon
Williams-Sonoma
WSM
+$39.5M
2
ALKS icon
Alkermes
ALKS
+$38.6M
3
KO icon
Coca-Cola
KO
+$31.2M
4
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$28.8M
5
ALT icon
Altimmune
ALT
+$28.7M

Top Sells

Rank Stock Value
1
DBX icon
Dropbox
DBX
+$35.4M
2
DG icon
Dollar General
DG
+$35.3M
3
BIIB icon
Biogen
BIIB
+$32.4M
4
ATR icon
AptarGroup
ATR
+$32.3M
5
BBY icon
Best Buy
BBY
+$29M

Sector Composition

Rank Sector Weight
1 Healthcare 51.15%
2 Miscellaneous 22.28%
3 Consumer Discretionary 12.09%
4 Consumer Staples 9.81%
5 Industrials 2.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$812B
$368M 13.36%
11,000
+4,500
+69% +$1.49M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$80.4B
$240M 8.69%
16,000
+4,000
+33% +$602K
AVTX icon
3
Avalo Therapeutics
AVTX
$1.06B
$68.3M 2.48%
10,422
+35
+0.3% +$263K
SUPN icon
4
Supernus Pharmaceuticals
SUPN
$2.47B
$66.7M 2.42%
3,200,000
+992,000
+45% +$22.5M
ENR icon
5
Energizer
ENR
$1.44B
$65.7M 2.38%
1,678,000
+530,000
+46% +$24.3M
LNTH icon
6
Lantheus
LNTH
$6.57B
$61.3M 2.22%
4,836,000
+1,212,000
+33% +$16.6M
AZO icon
7
AutoZone
AZO
$48.4B
$60.4M 2.19%
51,291
+23,291
+83% +$27.5M
BMY icon
8
Bristol-Myers Squibb
BMY
$133B
$60.3M 2.19%
1,000,000
– –
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$58.5M 2.12%
900,000
+400,000
+80% +$26.2M
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
$57.2M 2.08%
500,000
– –
INCY icon
11
Incyte
INCY
$25.4B
$57.1M 2.07%
636,000
+200,000
+46% +$19.3M
VNDA icon
12
Vanda Pharmaceuticals
VNDA
$326M
$52.6M 1.91%
5,450,000
+650,000
+14% +$6.95M
REGN icon
13
Regeneron Pharmaceuticals
REGN
$83.2B
$47M 1.71%
84,000
+16,000
+24% +$9.7M
UNH icon
14
UnitedHealth
UNH
$359B
$46.8M 1.7%
150,000
-50,000
-25% -$15.4M
MDT icon
15
Medtronic
MDT
$119B
$44.5M 1.61%
428,000
-164,000
-28% -$16.5M
CPB icon
16
Campbell Soup
CPB
$6.39B
$44.3M 1.61%
916,000
+480,000
+110% +$23.7M
MRK icon
17
Merck
MRK
$366B
$43.5M 1.58%
549,152
+171,872
+46% +$13.5M
BLUE
18
DELISTED
bluebird bio
BLUE
$43.2M 1.57%
61,760
+17,910
+41% +$14M
ROST icon
19
Ross Stores
ROST
$72.7B
$41.1M 1.49%
440,000
+30,656
+7% +$2.75M
WSM icon
20
Williams-Sonoma
WSM
$27.1B
$40.2M 1.46%
+890,000
New +$39.5M
AMAG
21
DELISTED
AMAG Pharmaceuticals
AMAG
$38.7M 1.4%
4,120,000
– –
ALKS icon
22
Alkermes
ALKS
$7.72B
$35.2M 1.28%
+2,124,000
New +$38.6M
CENTA icon
23
Central Garden & Pet Co Class A
CENTA
$2.22B
$35.1M 1.27%
1,215,000
-440,000
-27% -$12.6M
LOW icon
24
Lowe's Companies
LOW
$113B
$34.2M 1.24%
206,340
+70,924
+52% +$10.9M
FTDR icon
25
Frontdoor
FTDR
$5.65B
$33.9M 1.23%
872,000
+280,000
+47% +$12M
1
2 3 4 5

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Armistice Capital held 124 positions worth $2.76B, up 21% from $2.28B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $293M of net new capital in Q3 2020, opening 45 new positions and adding to 34 existing holdings. Its largest new stake was Williams-Sonoma: 890,000 shares worth $40.2M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 48% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Biogen, an estimated $32.4M trimmed.

  • Armistice Capital's largest Q3 2020 buy was Williams-Sonoma: 890,000 shares worth $40.2M.
  • Armistice Capital added most to AutoZone in Q3 2020, an estimated $27.5M increase.
  • Armistice Capital's biggest Q3 2020 reduction was Biogen, cutting an estimated $32.4M.
  • Armistice Capital fully exited Dropbox in Q3 2020, selling an estimated $35.4M.
  • Armistice Capital's ten largest holdings make up 40% of its $2.76B portfolio in Q3 2020.
  • Armistice Capital opened 45 new positions and closed 23 in Q3 2020.
  • Armistice Capital's portfolio value rose 21% quarter-over-quarter to $2.76B.

Based on Armistice Capital's 13F filing for Q3 2020, filed 16 Nov 2020.